Journey Medical (DERM) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $5.12, -2.94% vs the prior close of $5.28.
- Volume 220.30K shares, 1.1x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
DERM dips 2.9% to $5.12, a 3-month low, 4 down days in a row. Closed at $5.12, -2.94% vs the prior close of $5.28. Day range $5.09–$5.34, opened at $5.29.
DERM daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — DERM dips 2.9% to $5.12, a 3-month low, 4 down days in a row
- Closed at $5.12, -2.94% vs the prior close of $5.28. Day range $5.09–$5.34, opened at $5.29.
- Volume was 220.30K shares, 1.1x its 50-day average of 197.55K.
- Price is -25.3% vs its 50-day average ($6.86) and -24.4% vs its 200-day average ($6.78).
- 52-week range $4.31–$9.56; today's close sits at 16% of that range, 46.4% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — DERM slides 7.0% to $5.28, a 3-month low, 3 down days in a row
- Closed at $5.28, -7.04% vs the prior close of $5.68. Day range $5.24–$5.64, opened at $5.61.
- Volume was 188.70K shares, 1.0x its 50-day average of 197.05K.
- Price is -23.3% vs its 50-day average ($6.88) and -22.2% vs its 200-day average ($6.79).
- 52-week range $4.31–$9.56; today's close sits at 18% of that range, 44.7% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — DERM slides 3.9% to $5.68, a 3-month low
- Closed at $5.68, -3.89% vs the prior close of $5.91. Day range $5.66–$5.91, opened at $5.91.
- Volume was 200.70K shares, 1.0x its 50-day average of 198.02K.
- Price is -17.8% vs its 50-day average ($6.91) and -16.5% vs its 200-day average ($6.80).
- 52-week range $4.31–$9.56; today's close sits at 26% of that range, 40.6% below the 52-week high.
Oct 12, 2026 — DERM slides 6.3% to $5.91, a 3-month low
- Closed at $5.91, -6.34% vs the prior close of $6.31. Day range $5.89–$6.43, opened at $6.40.
- Volume was 266.10K shares, 1.4x its 50-day average of 193.64K.
- Price is -14.6% vs its 50-day average ($6.92) and -13.3% vs its 200-day average ($6.81).
- 52-week range $4.31–$9.56; today's close sits at 31% of that range, 38.1% below the 52-week high.
Oct 9, 2026 — DERM jumps 6.1% to $6.31
- Closed at $6.31, +6.05% vs the prior close of $5.95. Day range $5.95–$6.46, opened at $5.96.
- Volume was 156.90K shares, 0.8x its 50-day average of 192.15K.
- Price is -9.0% vs its 50-day average ($6.93) and -7.5% vs its 200-day average ($6.83).
- 52-week range $4.31–$9.56; today's close sits at 38% of that range, 34.0% below the 52-week high.
Oct 8, 2026 — DERM ends flat (+0.0%) to $5.95, 3 down days in a row
- Closed at $5.95, +0.00% vs the prior close of $5.95. Day range $5.89–$6.12, opened at $5.91.
- Volume was 250.10K shares, 1.3x its 50-day average of 190.82K.
- Price is -14.2% vs its 50-day average ($6.94) and -12.9% vs its 200-day average ($6.83).
- 52-week range $4.31–$9.56; today's close sits at 31% of that range, 37.7% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — DERM slides 3.4% to $5.95, a 3-month low
- Closed at $5.95, -3.41% vs the prior close of $6.16. Day range $5.89–$6.16, opened at $6.08.
- Volume was 205.40K shares, 1.1x its 50-day average of 189.30K.
- Price is -14.3% vs its 50-day average ($6.94) and -13.1% vs its 200-day average ($6.84).
- 52-week range $4.31–$9.56; today's close sits at 31% of that range, 37.7% below the 52-week high.
Oct 6, 2026 — DERM slides 7.9% to $6.16
- Closed at $6.16, -7.92% vs the prior close of $6.69. Day range $6.13–$6.73, opened at $6.69.
- Volume was 205.00K shares, 1.1x its 50-day average of 187.87K.
- Price is -11.3% vs its 50-day average ($6.95) and -10.1% vs its 200-day average ($6.85).
- 52-week range $4.31–$9.56; today's close sits at 35% of that range, 35.5% below the 52-week high.
Oct 5, 2026 — DERM rises 1.2% to $6.69
- Closed at $6.69, +1.21% vs the prior close of $6.61. Day range $6.49–$6.73, opened at $6.49.
- Volume was 88.70K shares, 0.5x its 50-day average of 192.36K — lighter than usual.
- Price is -3.7% vs its 50-day average ($6.95) and -2.5% vs its 200-day average ($6.86).
- 52-week range $4.31–$9.56; today's close sits at 45% of that range, 30.0% below the 52-week high.
Oct 2, 2026 — DERM dips 1.6% to $6.61
- Closed at $6.61, -1.64% vs the prior close of $6.72. Day range $6.47–$6.88, opened at $6.83.
- Volume was 126.20K shares, 0.7x its 50-day average of 193.91K.
- Price is -4.8% vs its 50-day average ($6.94) and -3.7% vs its 200-day average ($6.87).
- 52-week range $4.31–$9.56; today's close sits at 44% of that range, 30.8% below the 52-week high.
DERM latest news & SEC filings
Every SEC filing by or about DERM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 9, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $17.84M (prior year $15.01M) (+18.9% vs Jun 30, 2025)
- Net income: -$312.00K (prior year -$3.80M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.01 (prior year -$0.16) (loss narrowed vs Jun 30, 2025)
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 31, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 15, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 26, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade DERM
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 25, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.90% (largest 10.3%). That is a volatile stock.
- Liquidity: about 205.62K shares (≈$1.05M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $5.12 vs a range of $4.31–$9.56 (16% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-Q Aug 12, 2026; 8-K Aug 12, 2026; 8-K Jun 26, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
DERM market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 5.29 | 5.34 | 5.09 | 5.12 | 220.30K |
| Oct 14, 2026 | 5.61 | 5.64 | 5.24 | 5.28 | 188.70K |
| Oct 13, 2026 | 5.91 | 5.91 | 5.66 | 5.68 | 200.70K |
| Oct 12, 2026 | 6.40 | 6.43 | 5.89 | 5.91 | 266.10K |
| Oct 9, 2026 | 5.96 | 6.46 | 5.95 | 6.31 | 156.90K |
| Oct 8, 2026 | 5.91 | 6.12 | 5.89 | 5.95 | 250.10K |
| Oct 7, 2026 | 6.08 | 6.16 | 5.89 | 5.95 | 205.40K |
| Oct 6, 2026 | 6.69 | 6.73 | 6.13 | 6.16 | 205.00K |
| Oct 5, 2026 | 6.49 | 6.73 | 6.49 | 6.69 | 88.70K |
| Oct 2, 2026 | 6.83 | 6.88 | 6.47 | 6.61 | 126.20K |
| Oct 1, 2026 | 6.83 | 6.83 | 6.68 | 6.72 | 103.80K |
| Sep 30, 2026 | 6.52 | 6.89 | 6.43 | 6.84 | 167.20K |
| Sep 29, 2026 | 6.42 | 6.55 | 6.30 | 6.49 | 92.70K |
| Sep 28, 2026 | 6.11 | 6.49 | 6.08 | 6.43 | 148.40K |
| Sep 25, 2026 | 6.38 | 6.43 | 6.09 | 6.14 | 216.30K |
| Sep 24, 2026 | 6.43 | 6.64 | 6.20 | 6.32 | 364.60K |
| Sep 23, 2026 | 7.23 | 7.25 | 6.45 | 6.50 | 342.30K |
| Sep 22, 2026 | 7.04 | 7.40 | 6.97 | 7.25 | 227.40K |
| Sep 21, 2026 | 7.44 | 7.53 | 6.86 | 6.99 | 281.90K |
| Sep 18, 2026 | 7.31 | 7.61 | 7.28 | 7.31 | 259.80K |
About Journey Medical
Journey Medical (DERM) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SCOTTSDALE, AZ. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1867066.
DERM board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Neil Herskowitz | Director | Jul 2, 2026 |
| Claude Maraoui | President & CEO | Apr 24, 2026 |
| Michael Cooper Pearce | Director | Jun 26, 2026 |
| Lindsay A Md Rosenwald | Director | Jun 26, 2026 |
| Justin Adam Smith | Director | Jul 2, 2026 |
| Miranda Jayne Toledano | Director | Jul 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Ramsey Alloush | Chief Operating Officer | Apr 24, 2026 |
| Joseph Benesch | CFO | Apr 24, 2026 |
| Claude Maraoui | President & CEO | Apr 24, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
DERM financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $61.24M | $-11.43M | -0.47 | $-12.44M |
| Dec 31, 2024 | $55.13M | $-14.67M | -0.72 | $-9.13M |
| Dec 31, 2023 | $59.66M | $-3.85M | -0.21 | $5.24M |
| Dec 31, 2022 | $71.00M | $-29.63M | -1.69 | $-13.53M |
| Dec 31, 2021 | $63.13M | $-43.99M | -4.32 | $-2.18M |
Latest balance sheet: total assets $98.36M, total liabilities $66.24M, cash $25.64M (as of Jun 30, 2026).
DERM earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $6.43 |
| May 13, 2026 | 8-K Item 2.02 (results) | $5.19 |
| Mar 25, 2026 | 8-K Item 2.02 (results) | $6.83 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $9.08 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $8.54 |
| May 14, 2025 | 8-K Item 2.02 (results) | $5.97 |
| Mar 26, 2025 | 8-K Item 2.02 (results) | $6.14 |
| Feb 5, 2025 | 8-K Item 2.02 (results) | $5.28 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $5.45 |
| Nov 4, 2024 | 8-K Item 2.02 (results) | $5.32 |
| Aug 12, 2024 | 8-K Item 2.02 (results) | — |
| May 13, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on DERM
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.